Kinase protein binding inhibitors

Details for Australian Patent Application No. 2010221294 (hide)

Owner University of Florida Research Foundation, Inc.

Inventors Golubovskaya, Vita; Ostrov, David A.; Cance, William G.

Agent Griffith Hack

Pub. Number AU-A-2010221294

PCT Pub. Number WO2010/102095

Priority 61/209,431 06.03.09 US

Filing date 4 March 2010

Wipo publication date 10 September 2010

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/102095 Priority application(s): WO2010/102095

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010221299-Method and apparatus for overvoltage protection of an inverter

2010221284-Stabilized reverse transcriptase fusion proteins